The global market for digital breast tomosynthesis (DBT) equipment is forecasted to attain USD 3,267.6 million by 2025, expanding at 8.9% CAGR to USD 7,664.8 million by 2035. In 2024, the revenue of ...

Large-Scale Study Confirms CanScan® Test Accurately Detects Early-Stage Cancers From a Simple Blood Draw ...

The ‘Easiest Exam’ campaign promotes early detection of breast cancer, amassing over 164 million impressions and encouraging ...

The global Breast Biopsy Devices Market, valued at US$2,255.0 million in 2024, is forecasted to grow at a robust CAGR of 6.5% ...

Thanks to artificial intelligence (AI), more women might soon benefit from targeted breast cancer treatment, a new study says ...

In the Philippines, breast cancer is the most common type of cancer among women, with over 33,000 new cases reported in 2022.

Population breast cancer screening using mammography, alongside effective treatment, has been shown to reduce breast cancer ...